Oric Pharmaceuticals (ORIC) Interest Expenses (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Interest Expenses came in at $99.6 million in Q1 2026, up 748.53% YoY from $11.7 million in Q1 2025, and up 24.04% on a QoQ basis from $80.3 million in Q3 2025.
Oric Pharmaceuticals (ORIC) Interest Expenses (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Interest Expenses data on file, last reported at $99.6 million in Q1 2026.
- Quarterly Interest Expenses rose 748.53% year-over-year to $99.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.6 million (up 748.53% YoY) and the FY2025 annual result came in at $212.6 million, up 23.2% from the prior year.
- Interest Expenses rose to $99.6 million in Q1 2026, from $80.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $172.6 million in Q4 2024 to a low of $2.3 million in Q3 2022.
- A 5-year average of $55.6 million and a median of $40.6 million in 2023 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 25261.25% in 2022, down 95.21% in 2022.
- Tracing ORIC's Interest Expenses over 5 years: stood at $101.4 million in 2022, then surged by 31.07% to $133.0 million in 2023, then climbed by 29.78% to $172.6 million in 2024, then sank by 53.47% to $80.3 million in 2025, then increased by 24.04% to $99.6 million in 2026.
- The last three Interest Expenses figures came in at $99.6 million (Q1 2026), $80.3 million (Q3 2025), and $56.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 69.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.53 Mn |
| Jun 30, 2026 | 69.53 Mn |
| Mar 31, 2026 | 99.60 Mn |
| Mar 31, 2026 | 99.60 Mn |
| Sep 30, 2025 | 80.30 Mn |
| Sep 30, 2025 | 80.30 Mn |
| Jun 30, 2025 | 56.35 Mn |
| Jun 30, 2025 | 56.35 Mn |
| Mar 31, 2025 | 11.74 Mn |
| Mar 31, 2025 | 11.74 Mn |
| Dec 31, 2024 | 172.56 Mn |
| Dec 31, 2024 | 172.56 Mn |
| Sep 30, 2024 | 51.74 Mn |
| Sep 30, 2024 | 51.74 Mn |
| Jun 30, 2024 | 23.10 Mn |
| Jun 30, 2024 | 23.10 Mn |
| Mar 31, 2024 | 89.20 Mn |
| Mar 31, 2024 | 89.20 Mn |
| Dec 31, 2023 | 132.97 Mn |
| Dec 31, 2023 | 132.97 Mn |